Data as of Dec 06
| -0.1099 / -13.74%|
The 1 analysts offering 12-month price forecasts for Orgenesis Inc have a median target of 4.34, with a high estimate of 4.34 and a low estimate of 4.34. The median estimate represents a +528.99% increase from the last price of 0.69.
The current consensus among 1 polled investment analysts is to Buy stock in Orgenesis Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.